Date:
Saturday, January 31, 2026

Time:
7:30AM - Registration / Continental Breakfast

8:30AM - Program Starts

2:30PM - Program Concludes

Venue:
CONVENE/etc.venues, 601 Lexington Ave. New York City, NY  10022

Registration Fees:
Physician: $75
NY Metropolitan Breast Cancer Group Member: $50
Nurse/Nurse Practitioner/ Physician Assistant: $35
Resident/Fellow: $25
Industry: $300

Regional Director
Joseph Sparano, MD

Agenda (Times Subject To Change)

7:30 AM - 8:30 AMRegistration, Continental Breakfast, Exhibits Open  
8:30 AM - 8:45 AMWelcome and Introduction of Program and Faculty Pre-Knowledge AssessmentJoseph Sparano, MD, FACPJoseph Sparano, MD, FACP
8:45 AM - 9:15 AMNew Directions in Breast Cancer Prevention and Approaches to Risk ReductionDawn Hershman, MD, MS, FASCODawn Hershman, MD, MS, FASCO
9:15 AM - 9:50 AMInsights in Translational Research and Resistance MechanismsLajos Pusztai, MD, DPhilLajos Pusztai, MD, DPhil
9:50 AM - 10:25 AMUpdates in HR+ DiseaseNeil Vasan, MD, PhDNeil Vasan, MD, PhD
10:25 AM - 10:40 AMPanel Question and Answer Session  
10:40 AM - 10:55 AMRefreshment Break with Exhibitors  
10:55 AM - 11:25 AMAdvances in Approaches to Local-Regional Disease (Surgical and Radiation) Sheldon Feldman, MDSheldon Feldman, MD
11:25 AM - 12:10 PMUpdates in TNBC and HER2+ DiseaseAmy Tiersten, MDAmy Tiersten, MD
12:10 PM - 1:10 PMLunch Break and Supported Symposium - Exhibits Open  
1:10 PM - 1:40 PMBiomarker Discoveries and Clinical application of AIJoseph Sparano, MD, FACPJoseph Sparano, MD, FACP
1:40 PM - 1:55 PMPanel Question and Answer and Clinical Case Discussion  
1:55 PM - 2:10 PMWrap-up and Post Test  
2:10 PMAdjournment  

Best of SABCS® East is organized in partnership with the NY Metropolitan Breast Cancer Group

Program Overview

Breast cancer research continues to advance scientific and clinical knowledge of the disease and bring new techniques, treatments, and strategies to practicing clinicians. As such, clinicians need to stay current with best practices and clinical updates in prevention, screening, diagnosis, and treatment of breast cancer. Understanding results from recent clinical trials and key topics in breast cancer will help clinicians optimize management of patients with breast cancer and ultimately improve patient outcomes.

Learning Objectives

After participating in the Best of SABCS®️ program, learners will be able to:

1.⁠ ⁠INTERPRET recent advancements and research in breast cancer diagnosis, treatment, and specific considerations to enhance the care and outcomes of a diverse community of cancer patients.


2.⁠ ⁠LEVERAGE recent developments in the assessment and management of breast cancer subtypes to identify the most appropriate treatment strategies for people with breast cancer.


3.⁠ ⁠CONSTRUCT risk-adapted management strategies to optimize patient satisfaction, adherence, and treatment efficacy.


4.⁠ ⁠INTEGRATE new evidence from clinical trials in all aspects of breast cancer care presented during poster presentations and educational sessions at the annual San Antonio Breast Cancer Symposium into clinical practice in order to improve patient care.

Target Audience

This official Best of SABCS program is directed to practicing oncologists (medical, surgical, radiation), community physicians, medical residents and fellows training in oncology, as well as other pertinent healthcare professionals involved in oncology medicine.

Accreditation Statement

The University of Texas at San Antonio is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

The University of Texas at San Antonio designates this live activity up to a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation. 

This Program is Supported with Educational Grants from
AstraZeneca, Daiichi Sankyo, Exact Sciences, Genentech, Lilly, Novartis, Puma Biotechnology and Stemline/ Menarini

Interested in Exhibiting
www.bestofsabcs.com/sponsorship